# Reduced Dose Radiotherapy for the Treatment of Indolent Non-Hodgkin Lymphoma

> **NCT06386315** · PHASE2 · RECRUITING · sponsor: **Mayo Clinic** · enrollment: 112 (estimated)

## Conditions studied

- Indolent B-Cell Non-Hodgkin Lymphoma
- Recurrent Indolent B-Cell Non-Hodgkin Lymphoma
- Refractory Indolent B-Cell Non-Hodgkin Lymphoma
- Recurrent Indolent Non-Hodgkin Lymphoma
- Refractory Indolent Non-Hodgkin Lymphoma

## Interventions

- **PROCEDURE:** Computed Tomography
- **PROCEDURE:** Endoscopic Procedure
- **RADIATION:** Involved-site Radiation Therapy (3 Fractions)
- **RADIATION:** Involved-site Radiation Therapy (12 Fractions)
- **PROCEDURE:** Positron Emission Tomography
- **OTHER:** Questionnaire Administration

## Key facts

- **NCT ID:** NCT06386315
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-15
- **Primary completion:** 2027-05-30
- **Final completion:** 2027-05-30
- **Target enrollment:** 112 (ESTIMATED)
- **Last updated:** 2026-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06386315

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06386315, "Reduced Dose Radiotherapy for the Treatment of Indolent Non-Hodgkin Lymphoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06386315. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*